Company Filing History:
1 out of 1 
1 out of 116 
Years Active: 2022
Title: Herman Augustinus De Kock: Innovator in Cystic Fibrosis Treatment
Introduction
Herman Augustinus De Kock is a notable inventor based in Mechelen, Belgium. He has made significant contributions to the field of medicine, particularly in the treatment of cystic fibrosis. His innovative work has led to the development of a patent that addresses critical health challenges faced by individuals with this condition.
Latest Patents
Herman Augustinus De Kock holds a patent for "Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use." This invention relates to prodrug compounds and their application in treating cystic fibrosis. It includes methods for producing these compounds, pharmaceutical compositions that incorporate them, and treatment methods for cystic fibrosis through the administration of these innovative compounds.
Career Highlights
Throughout his career, De Kock has worked with prominent companies in the pharmaceutical industry, including AbbVie Global Enterprises Ltd. and Galapagos NV. His experience in these organizations has allowed him to contribute to significant advancements in medical research and drug development.
Collaborations
Herman has collaborated with notable professionals in his field, including Didier Philippe Robert Schils and Sam Bob Corveleyn. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in cystic fibrosis treatment.
Conclusion
Herman Augustinus De Kock is a distinguished inventor whose work has the potential to improve the lives of many individuals suffering from cystic fibrosis. His dedication to innovation and collaboration in the pharmaceutical industry underscores the importance of continued research in this vital area of healthcare.